Faecal calprotectin as reliable non-invasive marker to assess the severity of mucosal inflammation in children with inflammatory bowel disease

被引:152
作者
Canani, R. Berni [1 ,2 ]
Terrin, G. [1 ]
Rapacciuolo, L. [1 ,2 ]
Miele, E. [1 ]
Siani, M. C. [1 ]
Puzone, C. [1 ]
Cosenza, L. [1 ]
Staiano, A. [1 ,2 ]
Troncone, R. [1 ,2 ]
机构
[1] Univ Naples Federico II, Dept Pediat, I-80131 Naples, Italy
[2] Univ Naples Federico II, Lab Invest Food Induced Dis, I-80131 Naples, Italy
关键词
Crohn's disease; disease activity; endoscopy; microscopic inflammation; ulcerative colitis;
D O I
10.1016/j.dld.2008.01.017
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background. An accurate monitoring of mucosal inflammation is important for an effective management of patients with inflammatory bowel disease. Intestinal inflammation can be detected by faecal calprotectin level determination. Aim. To comparatively evaluate the accuracy of faecal calprotectin, clinical scores, common serum markers and endoscopy in the assessment of the severity of intestinal mucosa inflammation in children with inflammatory bowel disease. Methods. Fifty-eight paediatric patients (mean age 13.9 years, 95% CI 2.9-14.8; male 28) with confirmed inflammatory bowel disease (26 Crohn's disease, 32 ulcerative colitis) were enrolled. Before endoscopy, all patients underwent a complete evaluation including: clinical scores, erythrocyte sedimentation rate, C-reactive protein and faecal calprotectin determination. The severity of mucosal inflammation was assessed using specific endoscopic and histologic scores. Results. Faecal calprotectin showed a high correlation (r = 0.655) with the histologic grade of mucosal inflammation, similar to that observed for endoscopy (r = 0.699), and it resulted the most accurate tool (sensitivity 94%, specificity 64%, positive predictive value 81%, negative predictive value 87%) to detect the presence of active mucosal inflammation when compared to clinical scores and common serum markers. In patients with apparent clinical and laboratory remission the accuracy of faecal calprotectin resulted further improved (sensitivity 100%, specificity 80%, positive predictive value 67%, negative predictive value 100%). Conclusions. A more accurate assessment of the severity of mucosal inflammation can be achieved by the determination of faecal calprotectin levels compared to other common clinical and laboratory indices. This non-invasive and objective method could be particular useful in patients with apparent clinical and laboratory remission. (c) 2008 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:547 / 553
页数:7
相关论文
共 32 条
[1]   Review article: is clinical remission the optimum therapeutic goal in the treatment of Crohn's disease [J].
Arnott, IDR ;
Watts, D ;
Ghosh, S .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2002, 16 (05) :857-867
[2]   Fecal calprotectin: Validation as a noninvasive measure of bowel inflammation in childhood inflammatory bowel disease [J].
Bunn, SK ;
Bisset, WM ;
Main, MJC ;
Gray, ES ;
Olson, S ;
Golden, BE .
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2001, 33 (01) :14-22
[3]   Fecal calprotectin as a measure of disease activity in childhood inflammatory bowel disease [J].
Bunn, SK ;
Bisset, WM ;
Main, MJC ;
Golden, BE .
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2001, 32 (02) :171-177
[4]   Short- and long-term therapeutic efficacy of nutritional therapy and corticosteroids in paediatric Crohn's disease [J].
Canani, R. Berni ;
Terrin, G. ;
Borrelli, O. ;
Romano, M. T. ;
Manguso, F. ;
Coruzzo, A. ;
D'Armiento, F. ;
Romeo, E. F. ;
Cucchiara, S. .
DIGESTIVE AND LIVER DISEASE, 2006, 38 (06) :381-387
[5]   Combined use of Noninvasive tests is useful in the initial diagnostic approach to a child with suspected inflammatory bowel disease [J].
Canani, RB ;
de Horatio, LT ;
Terrin, G ;
Romano, MT ;
Miele, E ;
Staiano, A ;
Rapacciuolo, L ;
Polito, G ;
Bisesti, T ;
Manguso, F ;
Vallone, G ;
Sodano, A ;
Troncone, R .
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2006, 42 (01) :9-15
[6]   Diagnostic value of faecal calprotectin in paediatric gastroenterology clinical practice [J].
Canani, RB ;
Rapacciuolo, L ;
Romano, MT ;
de Horatio, LT ;
Terrin, G ;
Manguso, F ;
Cirillo, P ;
Paparo, F ;
Troncone, R .
DIGESTIVE AND LIVER DISEASE, 2004, 36 (07) :467-470
[7]   CORRELATIONS BETWEEN CLINICAL ACTIVITY, ENDOSCOPIC SEVERITY, AND BIOLOGICAL PARAMETERS IN COLONIC OR ILEOCOLONIC CROHNS-DISEASE - A PROSPECTIVE MULTICENTER STUDY OF 121 CASES [J].
CELLIER, C ;
SAHMOUD, T ;
FROGUEL, E ;
ADENIS, A ;
BELAICHE, J ;
BRETAGNE, JF ;
FLORENT, C ;
BOUVRY, M ;
MARY, JY ;
MODIGLIANI, R ;
COLOMBEL, JF ;
CORTOT, A ;
LESCUT, D ;
BITOUN, A ;
LEMANN, M ;
SALMERON, M ;
THEROND, JP ;
VERNISSE, B ;
SEE, A ;
RAOUL, JL .
GUT, 1994, 35 (02) :231-235
[8]   Role of faecal calprotectin as non-invasive marker of intestinal inflammation [J].
Costa, F ;
Mumolo, MG ;
Bellini, M ;
Romano, MR ;
Ceccarelli, L ;
Arpe, P ;
Sterpi, C ;
Marchi, S ;
Maltinti, G .
DIGESTIVE AND LIVER DISEASE, 2003, 35 (09) :642-647
[9]   Clinical applications of technetium Tc 99m hexamethyl propylene amine oxime leukocyte scan in children with inflammatory bowel disease [J].
Del Rosario, MA ;
Fitzgerald, JF ;
Siddiqui, AR ;
Chong, SK ;
Croffie, JM ;
Gupta, SK .
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 1999, 28 (01) :63-70
[10]   Treatment of inflammatory bowel disease in childhood:: Best available evidence [J].
Escher, JC ;
Taminiau, JAJM ;
Nieuwenhuis, EES ;
Büller, HA ;
Grand, RJ .
INFLAMMATORY BOWEL DISEASES, 2003, 9 (01) :34-58